Filing Flows › Biolife Solutions (BLFS) › Q2 2026 › vs Q2 2025
Biolife Solutions (BLFS) Q2 2026 vs Q2 2025 (year over year)
Biolife Solutions's revenue rose $5.0M (+21%) from $23.4M in Q2 2025 to $28.5M in Q2 2026. Gross margin 64.2% against 65.0% (-0.8 pts).
Biolife Solutions, Q2 2026: revenue $28.5M (+22% year over year), operating margin 6.0%, net earnings $45.1M, operating cash flow $6.3M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 64.2% | 65.0% | -0.8 pts |
| Operating margin | 6.0% | -68.8% | +74.8 pts |
| Net margin | 158.4% | -67.6% | +226.0 pts |
| Free cash flow margin | 18.6% | 24.0% | -5.4 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $28.5M | $23.4M | $5.0M | +21% |
| Gross profit | $18.3M | $15.2M | $3.1M | +20% |
| Cost of revenue | $10.2M | $8.2M | $2.0M | +24% |
| Other income, net | $1.1M | $414K | $643K | +155% |
| Operating profit | $1.7M | −$16.1M | $17.8M | — |
| Operating expenses | $16.6M | $31.4M | −$14.8M | -47% |
| Pre-tax earnings | $2.8M | −$15.7M | $18.5M | — |
| Research & development | $3.0M | $2.0M | $993K | +51% |
| Sales & marketing | $2.8M | $2.6M | $205K | +8% |
| General & admin | $10.7M | $11.2M | −$538K | -5% |
| Other operating costs | $157K | $15.6M | −$15.4M | -99% |
| Income tax benefit | $42.4M | −$126K | $42.5M | — |
| Net earnings | $45.1M | −$15.8M | $60.9M | — |
| Depreciation & amortization | $411K | $674K | −$263K | -39% |
| Share-based compensation | $3.9M | $5.9M | −$2.0M | -34% |
| Working capital & other | $43.0M | −$16.7M | $59.7M | — |
| Operating cash flow | $6.3M | $7.4M | −$1.0M | -14% |
| Free cash flow (OCF − capex) | $5.3M | $5.6M | −$320K | -6% |
| Capital expenditures | $1.0M | $1.7M | −$700K | -40% |
Questions
How much did Biolife Solutions's revenue grow year over year in Q2 2026?
Biolife Solutions's revenue rose $5.0M (+21%) from $23.4M in Q2 2025 to $28.5M in Q2 2026. Gross margin 64.2% against 65.0% (-0.8 pts).